LUDOVINI, VIENNA
 Distribuzione geografica
Continente #
NA - Nord America 1.022
AS - Asia 822
EU - Europa 668
SA - Sud America 151
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.690
Nazione #
US - Stati Uniti d'America 979
SG - Singapore 394
IT - Italia 171
BR - Brasile 123
IE - Irlanda 120
CN - Cina 118
HK - Hong Kong 96
VN - Vietnam 88
RU - Federazione Russa 82
DE - Germania 77
FR - Francia 52
FI - Finlandia 34
SE - Svezia 31
GB - Regno Unito 25
KR - Corea 25
CA - Canada 18
IN - India 18
MX - Messico 17
AR - Argentina 12
IQ - Iraq 12
AT - Austria 11
PL - Polonia 11
ZA - Sudafrica 11
JP - Giappone 9
RO - Romania 9
TR - Turchia 9
BD - Bangladesh 8
PK - Pakistan 8
UA - Ucraina 8
ES - Italia 7
CH - Svizzera 6
JO - Giordania 6
MA - Marocco 6
NL - Olanda 6
ID - Indonesia 5
BO - Bolivia 4
PY - Paraguay 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
GR - Grecia 3
MY - Malesia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
MT - Malta 2
OM - Oman 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GN - Guinea 1
HN - Honduras 1
IR - Iran 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MU - Mauritius 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
PW - Palau 1
RE - Reunion 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 2.690
Città #
Singapore 307
Chandler 168
Dublin 120
San Jose 117
Hong Kong 96
Perugia 85
Ashburn 77
Munich 52
Boardman 47
Santa Clara 38
San Mateo 37
Beijing 33
Moscow 28
Dong Ket 25
Seoul 24
The Dalles 24
Altamura 22
Ho Chi Minh City 22
Lauterbourg 22
Ann Arbor 21
Helsinki 21
Medford 21
Princeton 21
Los Angeles 19
Lawrence 18
Andover 15
Redmond 14
São Paulo 13
Hanoi 12
Mexico City 11
New York 11
Warsaw 11
Bucharest 9
Dearborn 9
Piscataway 9
Johannesburg 8
Montreal 8
Tokyo 8
Chennai 7
Nuremberg 7
Vienna 7
Frankfurt am Main 6
Saint Petersburg 6
San Paolo di Civitate 6
Turku 6
Wilmington 6
Amman 5
Atlanta 5
Baghdad 5
Brasília 5
Falkenstein 5
Haiphong 5
Hefei 5
Houston 5
London 5
Stockholm 5
Arezzo 4
Dallas 4
Denver 4
Guangzhou 4
Lahore 4
Norwalk 4
Orem 4
Paris 4
Phoenix 4
Rio de Janeiro 4
Rome 4
Seattle 4
Tianjin 4
Ankara 3
Boston 3
Calgary 3
Canoas 3
Chicago 3
Columbus 3
Curitiba 3
Erbil 3
Formia 3
Hải Dương 3
Istanbul 3
Montalto delle Marche 3
Poplar 3
Redwood City 3
Salvador 3
Tashkent 3
Tirana 3
Vicenza 3
Algiers 2
Aracaju 2
Asso 2
Baoding 2
Bexley 2
Bishkek 2
Biên Hòa 2
Bologna 2
Campinas 2
Cape Town 2
Caracas 2
Formosa 2
Lappeenranta 2
Totale 1.836
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 193
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer 124
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung 117
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer 116
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer 107
Large Cell Neuroendocrine Carcinoma Transformation and EGFR-T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer 106
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 103
Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy 96
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 96
Modified gene expression of alveolar-capillar membrane, extracellular matrix and membrane proteins after induction chemotherapy for Non-Small Cell Lung Cancer 96
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 95
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients 94
Pathway Activation Mapping of Kras Wild Type and Mutated Adenocarcinomas of the Lung: New Implications For Patient Stratification For Map Kinase Pathway Inhibition 92
Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer 92
Liquid Biopsy in early Breast Cancer: A preliminary Report 92
PD-L1 quantification across tumor types using the reverse phase protein microarray: Implications for precision medicine 88
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools 83
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients 82
Sensitivity to immune checkpoint blockade in advanced non-small cell lung cancer patients with EGFR exon 20 insertion mutations 81
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer 75
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study 75
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases 74
Detection of egfr mutations in plasma cell-free tumor dna of tki-treated advanced-nsclc patients by three methodologies: Scorpion-arms, pnaclamp, and digital pcr 74
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients 73
Antigen-Presenting Signaling Events in the Tumor Ecology Associate with Response to Anti-PD-1 Treatment in Lung Cancer 70
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab 68
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations 66
RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature 62
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion 59
Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs 57
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 55
Totale 2.761
Categoria #
all - tutte 11.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.365


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 2 3 27
2021/2022181 1 25 3 6 3 2 0 63 24 14 16 24
2022/2023438 21 84 5 54 39 30 0 21 163 3 15 3
2023/2024175 12 8 16 5 5 1 40 2 7 4 38 37
2024/2025502 7 35 42 16 54 41 14 42 81 45 75 50
2025/20261.205 76 87 67 162 184 104 218 70 139 98 0 0
Totale 2.761